Markus Räsänen

Person

Latest publications

  1. Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion Injury

    Magga, J., Vainio, L., Kilpio, T., Hulmi, J. J., Taponen, S., Lin, R., Räsänen, M., Szabo, Z., Gao, E., Rahtu-Korpela, L., Alakoski, T., Ulvila, J., Laitinen, M., Pasternack, A., Koch, W. J., Alitalo, K., Kivela, R., Ritvos, O. & Kerkelä, R., 6 Mar 2019, In : Molecular therapy. 27, 3, p. 600-610 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  2. Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types

    He, L., Vanlandewijck, M., Mäe, M. A., Andrae, J., Ando, K., Gaudio, F. D., Nahar, K., Lebouvier, T., Laviña, B., Gouveia, L., Sun, Y., Raschperger, E., Segerstolpe, Å., Liu, J., Gustafsson, S., Räsänen, M., Zarb, Y., Mochizuki, N., Keller, A., Lendahl, U. & 1 othersBetsholtz, C., 21 Aug 2018, In : Scientific data . 5, 11 p., 180160.

    Research output: Contribution to journalArticleScientificpeer-review

  3. Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle

    Hulmi, J. J., Nissinen, T. A., Räsänen, M., Degerman, J., Lautaoja, J. H., Hemanthakumar, K. A., Backman, J. T., Ritvos, O., Silvennoinen, M. & Kivelä, R., Apr 2018, In : Journal of cachexia, sarcopenia and muscle. 9, 2, p. 417-432 16 p.

    Research output: Contribution to journalArticleScientificpeer-review

View all (8) »

ID: 26884450